Involvement of prostaglandins in an animal model of Shigella-related seizures

Journal of Neuroimmunology

Volumn 168, Issue 1-2, 2005, Pages 34-39

  Yuhas, Yael ^a,c   Weizman, Abraham ^a   Vanichkin, Alexey ^a   Ashkenazi, Shai ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c Beilinson Campus   (Israel)

Author keywords

Animal model; Prostaglandins; Seizures; Shigella

Indexed keywords

CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BRAIN DEPTH STIMULATION; BRAIN TISSUE; CONCENTRATION (PARAMETERS); INFLAMMATION; LD 50; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SHIGELLA; SHIGELLA DYSENTERIAE;

ANIMALS; CHI-SQUARE DISTRIBUTION; CYCLOOXYGENASE INHIBITORS; DINOPROST; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LETHAL DOSE 50; MALE; MICE; MICE, INBRED ICR; NITROBENZENES; PENTYLENETETRAZOLE; PROSTAGLANDIN D2; PROSTAGLANDINS; SEIZURES; SHIGELLA DYSENTERIAE; SULFONAMIDES;

EID: 25844494539     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.06.029     Document Type: Article

References (33)

1. E.E. Aeberhard, S.A. Henderson, N.S. Arabolos, J.M. Griscavage, F.E. Castro, C.T. Barrett, and L.J. Ignarro Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene Biochem. Biophys. Res. Commun. 208 1995 1053 1059
2. 2 Epilepsy Res. 30 1998 63 68
3. S. Ashkenazi Shigella infections in children: new insights Semin. Pediatr. Infect. Dis. 15 2004 246 252
4. E.J. Baik, E.J. Kim, S.H. Lee, and C.-H. Moon Cyclooxygnease-2 selective inhibitors aggravate kainic acid-induced seizure and neuronal cell death in the hippocampus Brain Res. 843 1999 118 129
5. J. Balter-Seri, Y. Yuhas, A. Weizman, Y. Nofech-Mozes, E. Kaminsky, and S. Ashkenazi Involvement of NO in Shigella-related seizures in an animal model Infect. Immun. 67 1999 6365 6368
6. N.M. Davies, A.J. McLachlan, R.O. Day, and K.M. Williams Clinical pharmacokinetics and pharmacodynamics of celecoxib cyclo-oxygenase-2 inhibitor Clin. Pharmacokinet. 38 2000 242 255
7. G. Di Girolamo, M. Farina, M.L. Riberio, D. Ogando, J. Aisemberg, A.R. de los Santos, M.L. Marti, and A.M. Franchi Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum Br. J. Pharmacol. 139 2003 1164 1170
8. U. Forstermann, R. Heldt, F. Knappen, and G. Hertting Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain Brain Res. 240 1982 303 310
9. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871 1875
10. S.I. Hamano, Y. Nakanishi, T. Nara, T. Seki, T. Ohtani, T. Oishi, K. Joh, T. Oikawa, Y. Muramatsu, Y. Ogawa, and S. Akashi Neurological manifestation of hemorrhagic colitis in the outbreak of Escherichia coli 0157:H7 infection in Japan Acta Paediatr. 82 1993 454 458
11. W.E. Kaufmann, P.F. Worley, J. Pegg, M. Bremer, and P. Isakson COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc. Natl. Acad. Sci. U. S. A. 93 1996 2317 2321
12. K.A. Kelley, L. Ho, D. Winger, J. Freire-Moar, C.B. Borelli, P.S. Aisen, and G.M. Pasinetti Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2 Am. J. Pathol. 155 1999 995 1004
13. W.A. Khan, U. Dhar, M.A. Salam, J.K. Griffiths, W. Rand, and M.L. Bennish Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome Pediatrics 103 1999 1 8
14. E. Kita, Y. Yunou, T. Kurioka, H. Harada, S. Yoshikawa, S. Mikasa, and N. Higashi Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli 0157:H7 Infect. Immun. 68 2000 1207 1214
15. S. Lacroix, and S. Rivest Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain J. Neurochem. 71 1998 452 466
16. P.E. Lipsky, P. Brooks, L.J. Crofford, R. DuBois, D. Graham, L.S. Simon, L.B.A. van de Putte, and S.B. Abramson Unresolved issue in the role of cyclooxygenase-2 in normal physiologic processes and disease Arch. Intern. Med. 160 2000 913 920
17. I. Matoth, F. Pinto, C. Sicsic, and T. Brenner Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells Neurosci. Res. 38 2000 209 212
18. A.D. O'Brien, V.L. Tesh, A. Donohue-Rolfe, M.P. Jackson, S. Olsnes, K. Sandvig, A.A. Lindberg, and G.T. Keusch Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis Curr. Top. Microbiol. Immunol. 180 1992 65 94
19. N. Quan, M. Whiteside, and M. Herkenham Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysacchardie Brain Res. 802 1998 189 197
20. H. Rantala, R. Tarkka, and M. Uhari Systematic review of the role of prostaglandins and their synthetase inhibitors with respect to febrile seizures Epilepsy Res. 46 2001 251 257
21. R. Raqib, B. Wretlind, J. Andersson, and A.A. Lindberg Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma J. Infect. Dis. 171 1995 376 384
22. M. Sayyah, M. Javad-Pour, and M. Ghazi-Khansar The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors, nitric oxide and prostaglandins Neuroscience 122 2003 1073 1080
23. D.I. Schmid, and D.E. Kohan Effect of shigatoxin-1 on arachidonic acid release by human glomerular epithelial cells Kidney Int. 60 2001 1026 1036
24. R. Schuligoi, R. Ulcar, B.A. Peskar, and R. Amann Effect of endotoxin treatment on the expression on cyclooxygenase-2 and prostaglandin synthases in spinal cord, dorsal root ganglia, and skin of rats Neuroscience 116 2003 1043 1052
25. Y. Shapira, A.A. Artru, G. Yadid, and E. Shohami Methylprednisolone does not decrease eicosanoid concentrations of edema in brain tissue or improve neurologic outcome after trauma in rats Anesth. Analg. 75 1992 238 244
26. S. Tutuncuoglu, N. Kutukculer, L. Kepe, C. Coker, A. Berdeli, and H. Tekgul Proinflammatory cytokines, prostaglandins and zinc in febrile convulsions Pediatr. Int. 43 2001 235 239
27. J.R. Vane, S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Annu. Rev. Pharmacol. Toxicol. 38 1998 97 120
28. Y. Yuhas, A. Weizman, G. Dinari, and S. Ashkenazi An animal model to study the neurotoxicity of bacterial toxins and its application to demonstrate that Shiga toxin and lipopolysacchardie cooperate in inducing neurologic disorders J. Infect. Dis. 171 1995 1244 1249
29. Y. Yuhas, L. Shulman, A. Weizman, E. Kaminsky, A. Vanichkin, and S. Ashkenazi Involvement of tumor necrosis factor-α and interleukin-1β in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae Infect. Immun. 67 1999 1455 1460
30. Y. Yuhas, Y. Nofech-Mozes, A. Weizman, and S. Ashkenazi Enhancement of pentylenetretrazole-induced seizures by S. dysenteriae in LPS-resistant C3H/HeJ mice: role of the host response Med. Microbiol. Immunol. 190 2002 173 178
31. Y. Yuhas, A. Weizman, and S. Ashkenazi Bi-directional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures Infect. Immun. 71 2003 2288 2291
32. Y. Yuhas, A. Weizman, G.P. Chrousos, H. Ovadia, and S. Ashkenazi Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures J. Neuroimmunol. 153 2004 36 39
33. H.-M. Zhang, Z.-L. Ou, and T. Yamamoto Anisodamine inhibits Shiga toxin type 2-mediated tumor necrosis factor-α production in vitro and in vivo Exp. Biol. Med. 226 2001 597 604